Effects of Various Adjuvants and a Viral Infection on the Antibody Specificity Toward Native or Cryptic Epitopes of a Protein Antigen
暂无分享,去创建一个
J. Coutelier | L. Roguin | L. Retegui | M. E. Loureiro | S. A. Longhi | V. J. Marino | K. Gomez | P. A. Mathieu
[1] R. Rowland,et al. Lactate dehydrogenase-elevating virus: an ideal persistent virus? , 1995, Springer Seminars in Immunopathology.
[2] J. Van Snick,et al. Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms , 2001, International immunology.
[3] V. Verhasselt,et al. From autoimmune responses to autoimmune disease: what is needed? , 2001, Journal of autoimmunity.
[4] F. Destefano,et al. Epidemiology of autoimmune reactions induced by vaccination. , 2001, Journal of autoimmunity.
[5] V E Schijns,et al. Immunological concepts of vaccine adjuvant activity. , 2000, Current opinion in immunology.
[6] Gómez,et al. Autoantibodies to Cryptic Epitopes Elicited by Infection with Lactate Dehydrogenase‐Elevating Virus , 2000, Scandinavian journal of immunology.
[7] Y. Shoenfeld,et al. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? , 2000, Journal of autoimmunity.
[8] N. Dimmock,et al. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide. , 1999, Vaccine.
[9] J. Coutelier,et al. Changes in the Specificity of Antibodies in Mice Infected with Lactate Dehydrogenase‐Elevating Virus , 1997, Scandinavian journal of immunology.
[10] R. Zinkernagel,et al. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity. , 1997, Journal of immunology.
[11] Y. Shoenfeld,et al. Vaccine-induced autoimmunity. , 1996, Journal of autoimmunity.
[12] J. Coutelier,et al. Interleukin-12 gene expression after viral infection in the mouse , 1995, Journal of virology.
[13] R. Gupta,et al. Adjuvants for human vaccines--current status, problems and future prospects. , 1995, Vaccine.
[14] Y. Shoenfeld,et al. The viral-autoimmunity relationship. , 1995, Viral immunology.
[15] J. Löwer,et al. Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations. , 1995, Vaccine.
[16] J. Coutelier,et al. Inhibition by lactate dehydrogenase-elevating virus of in vivo interleukin 4 production during immunization with keyhole limpet haemocyanin. , 1993, Cytokine.
[17] S. Szu,et al. Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL. , 1991, Journal of immunology.
[18] P. Coulie,et al. In vivo polyclonal B-lymphocyte activation elicited by murine viruses , 1990, Journal of virology.
[19] J. Snick,et al. IgG2a restriction of murine antibodies elicited by viral infections , 1987, The Journal of experimental medicine.
[20] J. Coutelier,et al. Rheumatoid factor production in 129/Sv mice: involvement of an intestinal infectious agent. , 1986, Journal of immunology.
[21] B. Mahy,et al. Lactate dehydrogenase-elevating virus. , 1985, The Journal of general virology.
[22] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[23] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.